Pitcairn Co. Sells 2,080 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Pitcairn Co. decreased its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 12.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,216 shares of the company’s stock after selling 2,080 shares during the quarter. Pitcairn Co.’s holdings in Avanos Medical were worth $366,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in AVNS. State Board of Administration of Florida Retirement System grew its holdings in Avanos Medical by 8.6% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 19,053 shares of the company’s stock worth $379,000 after acquiring an additional 1,516 shares in the last quarter. Tidal Investments LLC bought a new position in shares of Avanos Medical during the first quarter valued at approximately $439,000. Boston Partners purchased a new position in Avanos Medical during the first quarter valued at approximately $571,000. Azzad Asset Management Inc. ADV raised its stake in Avanos Medical by 8.5% in the second quarter. Azzad Asset Management Inc. ADV now owns 28,521 shares of the company’s stock worth $568,000 after buying an additional 2,223 shares in the last quarter. Finally, Natixis Advisors LLC lifted its holdings in Avanos Medical by 19.5% during the second quarter. Natixis Advisors LLC now owns 18,878 shares of the company’s stock worth $376,000 after buying an additional 3,077 shares during the period. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Avanos Medical Stock Performance

Shares of Avanos Medical stock opened at $19.16 on Wednesday. The company has a market capitalization of $880.59 million, a PE ratio of 56.97 and a beta of 0.92. The company has a 50-day simple moving average of $21.64 and a two-hundred day simple moving average of $21.56. Avanos Medical, Inc. has a one year low of $17.39 and a one year high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.